28545358|t|Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence
28545358|a|Angiogenesis is critical for the growth of tumor by supplying nutrients and oxygen that exacerbates the metastasis and progression of cancer. Noninvasive imaging of angiogenesis during the tumor therapeutic processes may provide novel opportunities for image-guided tumor management. Here, we want to develop a mouse animal model for assessing cancer progression and angiogenesis in the same individuals by molecular imaging. Breast cancer model was developed with mouse breast cancer cell line 4T1 carrying a reporter system encoding a triple fusion (TF) reporter gene consisting of renilla luciferase (Rluc), red fluorescent protein (RFP) and herpes simplex virus truncated thymidine kinase (HSV-ttk) in transgenic mice, which expressed firefly luciferase (Fluc) under the promoter of vascular endothelial growth factor receptor 2 (Vegfr2-luc). The mice were subsequently treated with ganciclovir (GCV) and the tumor angiogenesis was tracked by Fluc imaging and the growth status of tumor was monitored by imaging of Rluc simultaneously. Overall, this traceable breast cancer model can simultaneously image the tumor growth and angiogenesis in single individual, which may facilitate a better understanding the mechanisms of angiogenesis in the progression and regression of tumor.
28545358	0	17	Molecular Imaging	T060	C1537028
28545358	21	39	Tumor Angiogenesis	T191	C1519670
28545358	44	63	Therapeutic Effects	T201	C1527144
28545358	69	89	Dual Bioluminescence	T038	C0162404
28545358	90	102	Angiogenesis	T042	C0302600
28545358	106	114	critical	T080	C1511545
28545358	123	129	growth	T040	C0018270
28545358	133	138	tumor	T191	C0027651
28545358	142	151	supplying	T169	C1561604
28545358	152	161	nutrients	T168	C0678695
28545358	166	172	oxygen	T121,T123,T196	C0030054
28545358	178	189	exacerbates	T033	C0436331
28545358	194	204	metastasis	T046	C4255448
28545358	209	220	progression	T169	C0449258
28545358	224	230	cancer	T191	C0006826
28545358	232	243	Noninvasive	T185	C2986496
28545358	244	251	imaging	T060	C0011923
28545358	255	267	angiogenesis	T042	C0302600
28545358	279	284	tumor	T191	C0027651
28545358	285	306	therapeutic processes	T061	C0935606
28545358	319	324	novel	T080	C0205314
28545358	325	338	opportunities	T062	C0683937
28545358	343	355	image-guided	T061	C1171347
28545358	356	361	tumor	T191	C0027651
28545358	362	372	management	T058	C0376636
28545358	401	419	mouse animal model	T050	C2986594
28545358	424	433	assessing	T058	C0184514
28545358	434	440	cancer	T191	C0006826
28545358	441	452	progression	T046	C0242656
28545358	457	469	angiogenesis	T042	C0302600
28545358	482	493	individuals	T098	C0237401
28545358	497	514	molecular imaging	T060	C1537028
28545358	516	535	Breast cancer model	T050	C1511291
28545358	555	560	mouse	T015	C0025929
28545358	561	574	breast cancer	T191	C0678222
28545358	575	584	cell line	T025	C0085983
28545358	585	588	4T1	T025	C0007634
28545358	600	615	reporter system	T077	C1705915
28545358	616	624	encoding	T052	C2700640
28545358	627	659	triple fusion (TF) reporter gene	T028	C1533585
28545358	674	692	renilla luciferase	T116,T126,T130	C1450145
28545358	694	698	Rluc	T116,T126,T130	C1450145
28545358	701	724	red fluorescent protein	T116	C0960938
28545358	726	729	RFP	T116	C0960938
28545358	735	755	herpes simplex virus	T005	C0319232
28545358	756	782	truncated thymidine kinase	T116,T126	C0040078
28545358	784	791	HSV-ttk	T116,T126	C0040078
28545358	796	811	transgenic mice	T015	C0025936
28545358	829	847	firefly luciferase	T116,T126	C0311727
28545358	849	853	Fluc	T116,T126	C0311727
28545358	865	873	promoter	T114,T123	C0086860
28545358	877	922	vascular endothelial growth factor receptor 2	T116,T192	C0378796
28545358	924	934	Vegfr2-luc	T116,T192	C0378796
28545358	941	945	mice	T015	C0025929
28545358	964	971	treated	T169	C1522326
28545358	977	988	ganciclovir	T114,T121	C0017066
28545358	990	993	GCV	T114,T121	C0017066
28545358	1003	1021	tumor angiogenesis	T191	C1519670
28545358	1037	1041	Fluc	T116,T126	C0311727
28545358	1042	1049	imaging	T060	C0011923
28545358	1058	1064	growth	T040	C0018270
28545358	1065	1071	status	T080	C0449438
28545358	1075	1080	tumor	T191	C0027651
28545358	1098	1105	imaging	T060	C0011923
28545358	1109	1113	Rluc	T116,T126,T130	C1450145
28545358	1154	1173	breast cancer model	T050	C1511291
28545358	1193	1198	image	T170	C1704922
28545358	1203	1215	tumor growth	T191	C0598934
28545358	1220	1232	angiogenesis	T042	C0302600
28545358	1243	1253	individual	T098	C0237401
28545358	1285	1298	understanding	T041	C0162340
28545358	1303	1313	mechanisms	T169	C0441712
28545358	1317	1329	angiogenesis	T042	C0302600
28545358	1337	1348	progression	T046	C0242656
28545358	1353	1363	regression	T046	C0684320
28545358	1367	1372	tumor	T191	C0027651